- Home
- NERV vs SKK Comparison
NERV vs SKK Comparison
Compare NERV & SKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- SKK
- Stock Information
- Founded
- NERV 2007
- SKK 2013
- Country
- NERV United States
- SKK Singapore
- Employees
- NERV N/A
- SKK N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- SKK
- Sector
- NERV Health Care
- SKK
- Exchange
- NERV Nasdaq
- SKK NYSE
- Market Cap
- NERV 15.5M
- SKK 14.9M
- IPO Year
- NERV 2014
- SKK 2024
- Fundamental
- Price
- NERV $1.82
- SKK $0.81
- Analyst Decision
- NERV Hold
- SKK
- Analyst Count
- NERV 1
- SKK 0
- Target Price
- NERV $5.00
- SKK N/A
- AVG Volume (30 Days)
- NERV 77.1K
- SKK 212.2K
- Earning Date
- NERV 03-04-2025
- SKK 02-14-2025
- Dividend Yield
- NERV N/A
- SKK N/A
- EPS Growth
- NERV N/A
- SKK N/A
- EPS
- NERV N/A
- SKK N/A
- Revenue
- NERV N/A
- SKK $8,631,000.00
- Revenue This Year
- NERV N/A
- SKK N/A
- Revenue Next Year
- NERV N/A
- SKK N/A
- P/E Ratio
- NERV N/A
- SKK N/A
- Revenue Growth
- NERV N/A
- SKK N/A
- 52 Week Low
- NERV $1.77
- SKK $0.61
- 52 Week High
- NERV $7.53
- SKK $11.45
- Technical
- Relative Strength Index (RSI)
- NERV 34.70
- SKK N/A
- Support Level
- NERV $1.77
- SKK N/A
- Resistance Level
- NERV $2.05
- SKK N/A
- Average True Range (ATR)
- NERV 0.16
- SKK 0.00
- MACD
- NERV -0.04
- SKK 0.00
- Stochastic Oscillator
- NERV 6.41
- SKK 0.00
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About SKK SKK HOLDINGS LIMITED
SKK Holdings Ltd is a civil engineering service provider that specializes in subsurface utility works in Singapore. It construct and maintain various public works and infrastructure projects that serve the society and the environment. Its projects are primarily the subsurface work related to projects undertaken by the Public Utilities Board (PUB) and Singapore Telecommunications Limited. The nature of these projects is related to repairing of pumping mains, sewer maintenance and pipe cable laying.